Skip to content
World City Press – Lifestyle
Author:
Imbria Pharmaceuticals Inc.
Imbria Pharmaceuticals to Participate in Select Fall Healthcare Conferences
September 15, 2026
Imbria Pharmaceuticals Receives FDA Orphan Drug Designation for Ninerafaxstat for Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
June 24, 2026